Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma.
Di Martile M, Desideri M, Tupone MG, Buglioni S, Antoniani B, Mastroiorio C, Falcioni R, Ferraresi V, Baldini N, Biagini R, Milella M, Trisciuoglio D, Del Bufalo D. Di Martile M, et al. Among authors: desideri m. Oncogenesis. 2018 Feb 23;7(2):20. doi: 10.1038/s41389-018-0026-x. Oncogenesis. 2018. PMID: 29472530 Free PMC article.
microRNA-378a-5p iS a novel positive regulator of melanoma progression.
Tupone MG, D'Aguanno S, Di Martile M, Valentini E, Desideri M, Trisciuoglio D, Donzelli S, Sacconi A, Buglioni S, Ercolani C, Biagioni A, Fibbi G, Fattore L, Mancini R, Ciliberto G, Blandino G, Del Bufalo D. Tupone MG, et al. Among authors: desideri m. Oncogenesis. 2020 Feb 14;9(2):22. doi: 10.1038/s41389-020-0203-6. Oncogenesis. 2020. PMID: 32060259 Free PMC article.
Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells.
Di Martile M, Desideri M, De Luca T, Gabellini C, Buglioni S, Eramo A, Sette G, Milella M, Rotili D, Mai A, Carradori S, Secci D, De Maria R, Del Bufalo D, Trisciuoglio D. Di Martile M, et al. Among authors: desideri m. Oncotarget. 2016 Mar 8;7(10):11332-48. doi: 10.18632/oncotarget.7238. Oncotarget. 2016. PMID: 26870991 Free PMC article.
BCL-XL overexpression promotes tumor progression-associated properties.
Trisciuoglio D, Tupone MG, Desideri M, Di Martile M, Gabellini C, Buglioni S, Pallocca M, Alessandrini G, D'Aguanno S, Del Bufalo D. Trisciuoglio D, et al. Among authors: desideri m. Cell Death Dis. 2017 Dec 13;8(12):3216. doi: 10.1038/s41419-017-0055-y. Cell Death Dis. 2017. PMID: 29238043 Free PMC article.
Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb.
D'Aguanno S, Valentini E, Tupone MG, Desideri M, Di Martile M, Spagnuolo M, Buglioni S, Ercolani C, Falcone I, De Dominici M, Milella M, Rizzo MG, Calabretta B, Cota C, Anichini A, Trisciuoglio D, Del Bufalo D. D'Aguanno S, et al. Among authors: desideri m. J Exp Clin Cancer Res. 2018 Nov 19;37(1):278. doi: 10.1186/s13046-018-0933-x. J Exp Clin Cancer Res. 2018. PMID: 30454024 Free PMC article.
Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages.
Di Martile M, Farini V, Consonni FM, Trisciuoglio D, Desideri M, Valentini E, D'Aguanno S, Tupone MG, Buglioni S, Ercolani C, Gallo E, Amadio B, Terrenato I, Foddai ML, Sica A, Del Bufalo D. Di Martile M, et al. Among authors: desideri m. J Immunother Cancer. 2020 Apr;8(1):e000489. doi: 10.1136/jitc-2019-000489. J Immunother Cancer. 2020. PMID: 32269145 Free PMC article.
45 results